Gallant Therapeutics Announces Launch of JEDI Pivotal Study for First Allogeneic Stem Cell Therapy Targeting Feline Chronic ...
— Multicenter study to investigate safety and efficacy of allogeneic stem cell therapy in cats with refractory feline chronic gingivostomatitis (FCGS) — — Potential first-in-class therapy for a deadly disease with high unmet medical need SAN DIEGO, Dec. 06 …